• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?

作者信息

Birnbaum Yochai

机构信息

John S. Dunn Chair in Cardiology Research and Education, The Section of Cardiology, The Department of Medicine, Baylor College of Medicine, 7200 Cambridge Street, MS BCM620, Houston, TX, 77030, USA.

出版信息

Cardiovasc Drugs Ther. 2025 Feb;39(1):13-14. doi: 10.1007/s10557-024-07647-0. Epub 2024 Nov 12.

DOI:10.1007/s10557-024-07647-0
PMID:39531113
Abstract
摘要

相似文献

1
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?胰高血糖素样肽-1受体激动剂用于腹主动脉瘤？
Cardiovasc Drugs Ther. 2025 Feb;39(1):13-14. doi: 10.1007/s10557-024-07647-0. Epub 2024 Nov 12.
2
Glucagon-Like peptide-1: A new therapeutic target to treat abdominal aortic aneurysm?胰高血糖素样肽-1：治疗腹主动脉瘤的新治疗靶点？
Biochimie. 2018 Sep;152:149-154. doi: 10.1016/j.biochi.2018.06.026. Epub 2018 Jul 3.
3
Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better.胰高血糖素样肽-1 抑制小鼠腹主动脉瘤的进展：越早越好。
Cardiovasc Drugs Ther. 2024 Oct;38(5):873-884. doi: 10.1007/s10557-023-07456-x. Epub 2023 May 5.
4
Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.胰高血糖素样肽-1可预防大鼠腹主动脉瘤的发生。
Surg Today. 2016 Sep;46(9):1099-107. doi: 10.1007/s00595-015-1287-z. Epub 2015 Dec 13.
5
Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm - What Does the Evidence Show?糖尿病、肠促胰岛素治疗与胸主动脉瘤——证据表明了什么？
Curr Vasc Pharmacol. 2019;17(5):432-439. doi: 10.2174/1570161116666180828155622.
6
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.胰高血糖素样肽-1 受体激动剂：临床药理学的叙述性综述及其对围手术期实践的影响。
Anaesthesia. 2024 Jul;79(7):735-747. doi: 10.1111/anae.16306. Epub 2024 May 13.
7
Effect of glucagon-like peptide-1 receptor agonists in subjects with type 2 diabetes mellitus: A meta-analysis.胰高血糖素样肽-1 受体激动剂在 2 型糖尿病患者中的作用：一项荟萃分析。
J Clin Pharm Ther. 2021 Dec;46(6):1650-1658. doi: 10.1111/jcpt.13502. Epub 2021 Aug 5.
8
Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.基于肠降血糖素的 2 型糖尿病治疗药物：对疗效、安全性和患者满意度的直接比较的综述。
Int J Clin Pharm. 2013 Apr;35(2):159-72. doi: 10.1007/s11096-012-9729-9. Epub 2012 Dec 22.
9
Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents.将二肽基肽酶-4抑制剂和胰高血糖素样肽-1激动剂重新定位为潜在的神经保护剂。
Neural Regen Res. 2019 May;14(5):745-748. doi: 10.4103/1673-5374.249217.
10
Glucagon-like peptide-1 receptor agonist use in pregnancy: a review.胰高血糖素样肽-1受体激动剂在妊娠中的应用：综述
Am J Obstet Gynecol. 2025 Jan;232(1):17-25. doi: 10.1016/j.ajog.2024.08.024. Epub 2024 Aug 23.

引用本文的文献

1
Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications.胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂在神经性疼痛中的治疗作用：作用机制及临床意义
Biomolecules. 2025 Apr 26;15(5):622. doi: 10.3390/biom15050622.

本文引用的文献

1
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.《美国医师学院成人 2 型糖尿病新型药物治疗：系统评价和网络荟萃分析》
Ann Intern Med. 2024 May;177(5):618-632. doi: 10.7326/M23-1490. Epub 2024 Apr 19.
2
Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better.胰高血糖素样肽-1 抑制小鼠腹主动脉瘤的进展：越早越好。
Cardiovasc Drugs Ther. 2024 Oct;38(5):873-884. doi: 10.1007/s10557-023-07456-x. Epub 2023 May 5.
3
Abdominal aortic aneurysm: a review on the role of oral antidiabetic drugs.
腹主动脉瘤：口服抗糖尿病药物作用的综述。
Int Angiol. 2020 Aug;39(4):330-340. doi: 10.23736/S0392-9590.20.04362-X. Epub 2020 Apr 14.
4
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.利拉利汀通过靶向 Nlrp3/ASC 炎性小体抑制 DPP-4 可预防心脏功能障碍和炎症。
Basic Res Cardiol. 2019 Aug 6;114(5):35. doi: 10.1007/s00395-019-0743-0.
5
A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms.二肽基肽酶-4在腹主动脉瘤发生发展过程中通过介导单核细胞分化发挥的潜在作用。
J Vasc Surg. 2017 Oct;66(4):1217-1226.e1. doi: 10.1016/j.jvs.2016.05.093. Epub 2016 Nov 23.
6
Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.胰高血糖素样肽-1可预防大鼠腹主动脉瘤的发生。
Surg Today. 2016 Sep;46(9):1099-107. doi: 10.1007/s00595-015-1287-z. Epub 2015 Dec 13.
7
A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice.二肽基肽酶-4 抑制剂而非肠降血糖素可抑制血管紧张素 II 输注载脂蛋白 E 基因敲除小鼠的腹主动脉瘤。
J Atheroscler Thromb. 2016;23(4):441-54. doi: 10.5551/jat.31997. Epub 2015 Nov 9.
8
Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.二肽基肽酶-4抑制剂通过小鼠中依赖胰高血糖素样肽-1的单核细胞活性减少腹主动脉瘤形成。
PLoS One. 2015 Apr 14;10(4):e0121077. doi: 10.1371/journal.pone.0121077. eCollection 2015.
9
Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.口服二肽基肽酶-4抑制剂（阿格列汀）通过抗氧化作用预防大鼠腹主动脉瘤的形成。
J Vasc Surg. 2014 Apr;59(4):1098-108. doi: 10.1016/j.jvs.2013.04.048. Epub 2013 Jun 19.